Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 18701-18710 Newer>

The Motley Fool November 27, 2006 Brian Lawler	Roche Says Goodbye to PDL The larger pharmaceutical drops out of daclizumab development. Investors, take note.
The Motley Fool November 27, 2006 Tom Taulli	Euronet's Transfer of Power Euronet is now No. 3 in money transfer, with plans to get even bigger. Investors, take note.
The Motley Fool November 27, 2006 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Hormel... J&J Snack Foods... LCA-Vision... Lancaster Colony...
The Motley Fool November 27, 2006 Tom Taulli	Docucorp Stuck in Neutral With lackluster growth this year, the insurance-focused software firm has had little traction with its stock, which has spun its wheels at between $6 to $8 per share.
The Motley Fool November 27, 2006 David Lee Smith	Copper Companies Enliven Thanksgiving Freeport-McMoRan's merger bets on sustained copper prices. Investors, keep an eye on these companies since the quest for combinations among the producers likely has not been exhausted.
The Motley Fool November 27, 2006 Rich Smith	Foolish Forecast: Mechel, Once More The Russian metals and mining conglomerate is set to report third-quarter 2006 performance. Investors, do you want to know what Wall Street expects to see? Do you want to know what really matters?
The Motley Fool November 27, 2006 Selena Maranjian	Insiders and Institutions Why investors should pay attention to what percentage of a company's shares are owned by insiders or institutions.
The Motley Fool November 27, 2006 Stephen Ellis	A Dystopian Future for Investors Investors should consider the ramifications of the worst case scenarios for their companies.
The Motley Fool November 24, 2006 Rich Smith	Foolish Forecast: Sifting Through the Oil-Dri The largest manufacturer of kitty litter in the country is set to report its fiscal first-quarter 2007 earnings. Investors, take note.
The Motley Fool November 24, 2006 Brian Lawler	Amylin Gets Past the Formalities Following a formal approval from the EU for Byetta, Amylin can get down to business. Investors, take note.
<Older 18701-18710 Newer> Return to current articles.